Haleon expects 2026 organic revenue growth of around 2.5%
- Haleon now expects fiscal 2026 organic revenue growth of around 2.5%, retaining high-single-digit adjusted operating profit growth guidance at constant currency.
- Third-quarter organic revenue rose 2.6%, below expectations, as weak cold and flu demand weighed on North American orders.
- A raw material classification change halted imports of Centrum OTC products into China, also weighing on performance.
- Accelerating Brazil’s distribution overhaul is expected to reduce fourth-quarter net revenue by approximately £15 million to £20 million.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HALEON plc published the original content used to generate this news brief on October 29, 2026, and is solely responsible for the information contained therein.